人血小板裂解物市場：按類型、按應用、按最終用戶、按地區 - 規模、份額、展望、機會分析，2023-2030 年

一種名為人血小板裂解物的富含生長因子的細胞培養補充劑是在美國食品和藥物管理局 (FDA) 和加拿大衛生部許可的血液設施中由健康供體人血小板製成的。它是 多個供體單位在製造過程中匯集在一起，以減少批次間的差異。 為防止凝血，應添加抗凝血劑。 由人血小板製成的細胞培養生長補充劑稱為人血小板裂解物 (HPL)。 用 HPL 代替胎牛血清 (FBS) 消除了異種問題和牛朊病毒的傳播，從而提高了乾細胞產量和臨床級潛力。 用於細胞培養的人血小板裂解物補充劑可提供卓越的細胞性能和可重現的結果。 它也是標準化和安全的。 許多實驗和臨床研究項目都受益於人類血小板裂解物的開發。 人血小板裂解物不影響功能能力。 可以使用血漿、血清、臍帶血血清和血小板裂解物等人血來源物質代替胎牛血清。 人血小板裂解物用於多種應用，包括生物技術和製藥領域突破性療法的研發和製造。

市場動態

越來越多地採用無機策略，例如市場主要參與者的收購，預計這將在預測期內推動市場增長。 例如，2021 年 8 月，生物技術公司 BioLife Solutions 宣布收購生物技術公司 sexton biotechnologies，以擴大其細胞和基因治療工具的產品組合。 Sexton 的生物生產工具組合包括用於細胞治療最終劑量包裝的專有封閉小瓶、人血小板裂解物 (HPL) 培養基、用於細胞製造的胎牛血清或人血清的生物定義替代品、自動細胞處理機等。

這項研究的主要特點

• 本報告對全球人類血小板裂解物市場進行了深入分析，提供了以 2022 年為基準年的預測期 (2023-2030) 的市場規模和復合年增長率 (CAGR%)。我是這裡。
• 它揭示了各個細分市場的潛在收入機會，並描述了該市場具有吸引力的投資建議矩陣。
• 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
• 全球人血小板裂解物市場主要參與者的概況基於以下參數，包括公司亮點、產品組合、主要亮點、財務業績和戰略。
• 本研究涵蓋的主要公司包括 STEMCELL Technologies Inc.、Merck KGaA、Mill Creek Life Sciences、Merck & Co., Inc、AventaCell BioMedical、Compass Biomedical, Inc、Macopharma SA、Trinova Biochem GmbH、PL BioScience GmbH , Cook Regentec, Life Science Group Ltd., BBI Solutions, Regenexx, Thermo Fisher Scientific。
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 《全球人血小板裂解物市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球人類血小板裂解物市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫

第二章市場展望

• 報告概述
  • 市場定義和範圍
• 執行摘要
  • 市場概況：按類型分類
  • 市場概況：按應用分類
  • 市場概況：按最終用戶分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場機會
• 影響分析
• 市場趨勢
• 近期發展趨勢
• 收購和合作場景
• 技術概述
• 監管情景
• 害蟲分析

第 4 章全球人血小板裂解物市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 總體影響
• 對供需的影響
• COVID-19 對市場的影響

第 5 章全球人類血小板裂解物市場，按類型，2017-2030

• 基於肝素的人血小板裂解物
• 不含肝素的人血小板裂解物

第 6 章全球人類血小板裂解物市場應用，2017-2030

• 臨床應用
• 用於研究

第 7 章全球人類血小板裂解物市場：按最終用戶分類，2017-2030

• 生物製藥公司
• 簽約研發組織
• 其他

第 8 章全球人類血小板裂解物市場：地區，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第9章競爭格局

• STEMCELL Technologies Inc
• Merck KGaA
• Mill Creek Life Sciences
• Merck & Co., Inc
• AventaCell BioMedical
• Compass Biomedical, Inc
• Macopharma SA
• Trinova Biochem GmbH
• PL BioScience GmbH
• Cook Regentec
• Life Science Group Ltd
• BBI Solutions
• Regenexx
• Thermo Fisher Scientific

第 10 章

• 調查方法
• 關於出版商

A growth factor-rich cell culture supplement called human platelet lysate is made from healthy donor human platelets at blood facilities that are approved by both the U.S. Food and Drug Administration (FDA) and Health Canada. To reduce lot-to-lot variability, several donor units are pooled together during the production process. To prevent coagulation, an anticoagulant must be added. A supplement for cell culture growth made from human platelets is called human platelet lysate (HPL). By removing xenogeneic concerns and the spread of bovine prions, replacing foetal bovine serum (FBS) with HPL enables the increase and possible clinical grade production of stem cells. The human platelet lysate supplements for cell culture offer great cell performance and repeatable results. They are standardized and safe. Numerous experimental and clinical research projects have benefited from the development of human platelet lysates. Functional capacities are unaffected by human platelet lysates. Human blood-derived substances such as plasma, serum, umbilical cord blood serum, and platelet derivatives such platelet lysates can be used instead of FBS. Human platelet lysates have several uses, including biotechnology and pharmaceutical medication breakthrough therapy research, development, and production.

Market Dynamics

Increasing adoption of inorganic strategies by key players in market such as acquisitions is expected to drive market growth over the forecast period. For instance, in August 2021, BioLife Solutions, a biotechnology company, announced the acquisition of sexton biotechnologies, a biotechnology company, to expand cell and gene therapy tools portfolio. Sexton's bio production tools portfolio includes proprietary closed vials for cell therapy final dose packaging, human platelet lysate (HPL) media, a bio-defined replacement for fetal bovine serum or human serum used in cell manufacturing, and automated cell processing machines.

Key features of the study:

• This report provides in-depth analysis of the global human platelet lysate market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global human platelet lysate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include STEMCELL Technologies Inc., Merck KGaA, Mill Creek Life Sciences, Merck & Co., Inc, AventaCell BioMedical, Compass Biomedical, Inc, Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH, Cook Regentec, Life Science Group Ltd., BBI Solutions, Regenexx, Thermo Fisher Scientific.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global human platelet lysate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human platelet lysate market

Detailed Segmentation:

• Global Human Platelet Lysate Market, By Type:
  • Heparin - Based Human Platelet Lysate
  • Heparin - Free Human Platelet Lysate
• Global Human Platelet Lysate Market, By Application:
  • Clinical Use
  • Research Use
• Global Human Platelet Lysate Market, By End User:
  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Others
• Global Human Platelet Lysate Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • STEMCELL Technologies Inc
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
  • Mill Creek Life Sciences
  • Merck & Co., Inc
  • AventaCell BioMedical
  • Compass Biomedical, Inc
  • Macopharma SA
  • Trinova Biochem GmbH
  • PL BioScience GmbH
  • Cook Regentec
  • Life Science Group Ltd.
  • BBI Solutions
  • Regenexx
  • Thermo Fisher Scientific

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis

4. Global Human Platelet Lysate Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Human Platelet Lysate Market, By Type , 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Heparin - Based Human Platelet Lysate
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Heparin - Free Human Platelet Lysate
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Human Platelet Lysate Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Clinical Use
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Research Use
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Human Platelet Lysate Market, By End User, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Biopharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Contract Research Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Human Platelet Lysate Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• STEMCELL Technologies Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mill Creek Life Sciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck & Co., Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• AventaCell BioMedical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Compass Biomedical, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Macopharma SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Trinova Biochem GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• PL BioScience GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cook Regentec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Life Science Group Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BBI Solutions
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Regenexx
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us